Vandetanib
Back to search| Scientific Name: | Vandetanib |
| Brand Name: | Caprelsa |
| Company Owner: | Not Available |
| Mechanism Of Action | ZD-6474 is a potent and selective inhibitor of VEGFR (vascular endothelial growth factor receptor) , EGFR (epidermal growth factor receptor) and RET (REarranged during Transfection) tyrosine kinases. |
| Description of the Drug: | Vandetanib is an antineoplastic kinase inhibitor used to treat symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. |
| Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB05294
